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Abstract 
Background: Malaria, due to Plasmodium ovale, can be challenging to diagnose due to clinically mild disease and 
low parasite burden. Two genetically distinct sub-species of P. ovale exist: Plasmodium ovale curtisi (classic) and Plas-
modium ovale wallikeri (variant). It is presently unknown if the sub-species causing infection affects performance of 
malaria diagnostic tests. The aim of this work was to understand how the genetically distinct sub-species, P. o. curtisi 
and P. o. wallikeri, affect malaria diagnostic tests.
Methods: Plasmodium ovale-positive whole blood specimens were sub-speciated by PCR and sequencing of 18S 
rRNA and dhfr-ts. Parasitaemia, morphology, pan-aldolase positivity, 18S copy number, and dhfr-ts sequences were 
compared between sub-species.
Results: From 2006 to 2015, 49 P. ovale isolates were identified, of which 22 were P. o. curtisi and 27 P. o. wallikeri; 80% 
were identified in the last five years, and 88% were acquired in West Africa. Sub-species did not differ by parasitaemia, 
18S copy number, or pan-aldolase positivity. Lack of Schüffner’s stippling was over-represented among P. o. wallikeri 
isolates (p = 0.02). Several nucleotide polymorphisms between the sub-species were observed, but they do not occur 
at sites believed to relate to antifolate binding.
Conclusions: Plasmodium ovale is increasing among travellers to West Africa, although sub-species do not differ 
significantly by parasitologic features such as parasitaemia. Absence of Schüffner’s stippling may be a feature specific 
to P. o. wallikeri and is a novel finding.
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Background
Plasmodium ovale is one species of malaria parasites that 
is pathogenic to humans [1]. Prevalent in West and East 
Africa and the Asia–Pacific [1], P. ovale infections can be 
challenging to diagnose in part due to the typical presen-
tation of clinically mild disease and low parasite burden 
[2]. Consequently, conventional diagnostic tools, such 
as microscopy of blood films and rapid diagnostic tests 
(RDT), have limited performance in detecting P. ovale 
infection [3–5], often resulting in the use of molecular 
techniques to confirm the diagnosis [5].
Two genetically distinct sub-species of P. ovale exist: 
Plasmodium ovale curtisi and Plasmodium ovale wal-
likeri [7, 8], which are known as the classic and variant 
types, respectively. First recognized in 2010, these two 
sub-species are believed to have diverged one to two 
million years ago [7, 9]. Clinical differences between 
the two sub-species have not been clearly elucidated, 
although there have been differences found in latency 
period [9] and thrombocytopaenia [10]. At present, it is 
unknown if the performance of malaria diagnostic tests 
may differ between the sub-species, causing infection. It 
is known that the dihydrofolate reductase-thymidylate 
synthase (dhfr-ts) domain, a common anti-malarial drug 
target and a region that can be linked to antifolate resist-
ance, has been thoroughly investigated in Plasmodium 
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falciparum and Plasmodium vivax. However, investi-
gations into this region have only recently begun for P. 
ovale isolates [2, 8, 11]. Previous reports have implicated 
specific sites in the peptide sequence that may interfere 
with antifolate binding at the active site, which include 
D53, F57, S58, T61, S113, S116, I169, and T190 [8, 11]. 
R499/503 and C519/523 (P. ovale curtisi/P. ovale wal-
likeri) are also believed to be significant for thymidylate 
synthase activity, specifically [8]. As atovaquone-progua-
nil, the proguanil component of which is an antifolate, 
is one of the most commonly and empirically used anti-
malarials for travel-acquired malaria, it is important to 
understand if mutations in regions of dhfr-ts known to 
confer resistance in other species of malaria are present 
in P. ovale isolates, and if these mutations are specific to 
one sub-species over another.
Further understanding of parasitologic correlates of P. 
ovale sub-species may have important implications for 
diagnosis and management. The potential differences 
in parasite burden, RDT performance, morphology, 
and molecular diagnosis between P. ovale curtisi and P. 
ovale wallikeri were investigated. The DHFR-TS peptide 
sequence was also compared between isolates to investi-
gate potential mutations in regions known to confer anti-
folate resistance in other species of malaria.
Methods
Specimens
Plasmodium ovale-positive, whole blood specimens 
stored in the malaria biobank at Public Health Ontario 
Laboratories (PHOL) from October 2006 to July 2015 
were identified and retrieved. For the staining procedure, 
2  mL of standard Giemsa stain was diluted in 48  mL 
of phosphate buffer (pH 7.1) prior to use. The phos-
phate buffer consists of 65  mL of Na2HPO4, 35  mL of 
NaH2PO4, and 900 mL of distilled water, resulting in 4.35 
and 2.33 mM concentrations, respectively. For thin films, 
the slide was immersed in methanol for 10 s, allowed to 
dry, and then immersed in the working Giemsa solution 
for 10  min. The slide was then immersed in phosphate 
buffer solution for 10  s and air dried. Thick films were 
immersed in the working Giemsa solution for 10  min, 
immersed in the phosphate buffer for 30 s, and air dried. 
With each working solution prepared, a control P. falci-
parum slide was prepared and examined. Parasitaemia, 
morphological features, pan-aldolase antigen-positivity 
as determined by the BinaxNOW Malaria test (Alere, 
Ottawa, ON, Canada), year of import, and country of 
acquisition that were recorded in the biobank database 
following initial diagnostic processing were collected and 
analysed. The study was approved by the Research Ethics 
Board of Public Health Ontario.
DNA extraction
DNA of all specimens was extracted using the DNA Mini 
Kit Blood or Body Fluid Spin Protocol (Qiagen, Ger-
mantown, MD, USA). Prior to use, DNA was stored at 
−20 °C.
Qualitative and quantitative real‑time PCR
Plasmodium falciparum/P. vivax species-specific duplex 
[6] and Plasmodium malariae/P. ovale species-specific 
duplex real-time PCR (qPCR) assays were conducted to 
confirm microscopy species identification as previously 
described [12]. All qPCR assays were run under the fol-
lowing conditions using the ABI 7900HT qPCR system: 
50 °C for 2 min, 95 °C for 10 min, 95 °C for 15 s, and 60 °C 
for 1  min (45 cycles); 12.5  µl of TaqMan universal PCR 
master mix (Life Technologies, Burlington, ON, Canada) 
and 5  µl of DNA primers and probes with concentra-
tions as previously reported [6, 12, 13] were used, for a 
final volume of 25 µl per reaction. All qPCR amplification 
curves were analysed using a manual threshold cycle of 
0.02 and an automatic baseline. A cycle threshold (Ct) 
of <38 was considered to be a positive result.
18S rRNA gene copy numbers were quantified by run-
ning the P. malariae/P. ovale species-specific duplex 
qPCR assay and including serial dilutions of a P. ovale 
clone (ATCC, Manassas, VA, USA) alongside specimen 
DNA in triplicates. A linear regression was then con-
structed based on the logarithm of the gene copy number 
and Ct values for each concentration of the clone. This 
equation could then be used to calculate the gene copy 
number for each banked specimen.
Sequencing of 18S rRNA and dihydrofolate 
reductase‑thymidylate synthase
Endpoint PCR of target regions, visualization of the 
amplicons on agarose gel, and Sanger sequencing were 
conducted as previously described [12]. Specifically, 
endpoint PCR of a 396-bp product from the 18S rRNA 
region was conducted with high-fidelity polymerase 
AccuPrime Pfx Supermix (Life Technologies, Burling-
ton, ON, Canada) and 200  nM (each) of the primers 
Plasmo 18S forward (5′-ATTCAGATGTCAGAGGTG 
AAATTCT-3′) and Plasmo 18S reverse (5′-TCAATCC 
TACTCTTGTCTTAAACTA-3′). Using an ABI Veriti 
fast thermal cycler, the cycling conditions were 95 °C for 
5 min, followed by 95 °C for 15 s, 58 °C for 30 s, and 68 °C 
for 30 s for 45 cycles, and then 68  °C for 5 min. Ampli-
cons were visualized on 1% agarose gels with ethidium 
bromide prior to Sanger sequencing. For sequencing, 
the same forward and reverse primers were used along 
with a BigDye Terminator v3.1 cycle sequencing kit (Life 
Technologies, Burlington, ON, Canada), which was run 
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according to the manufacturer’s recommended condi-
tions. The products were purified by a BigDye XTermi-
nator (Life Technologies, Burlington, ON, Canada) and 
analysed with an ABI 3130xl genetic analyzer. Forward 
and reverse sequences of each sample were aligned using 
Vector NTI software (Life Technologies, Burlington, ON, 
Canada), and the sequences were verified using a BLAST 
search to confirm the sub-species identification [14].
Primers for sequencing the dhfr-ts gene were newly 
designed for this study. All primers were designed 
using Primer3 [15, 16] and predominantly conserved 
regions of the complete sequence of the P. ovale dhfr-
ts gene (GenBank: EU266602). Degenerate nucleo-
tides were included based on the dhfr-ts gene for P. o. 
curtisi (GenBank: KP050414) and P. o. wallikeri (Gen-
Bank: KP050415). Endpoint PCR of the dihydrofolate 
reductase-thymidylate synthase region was conducted 
on all specimens with high-fidelity polymerase Phusion 
(New England BioLabs, Ipswich, MA, USA) and 200 nM 
(each) of the primers PocPowDHFR-exF (5′-YTCWACC 
TTCAGGGGTATCG-3′) and PocPowDHFR-exR (5′-AG 
TTTWAGCGTGGGRAAAGG-3′), generating an 
approximately 1700-bp product that covers the 99th 
amino acid to 1814–1826th amino acid of the sequence, 
where the end target varies based on the sub-species. 
The cycling conditions were 98  °C for 30  min, followed 
by 98 °C for 10 s, 64 °C for 30 s, and 72 °C for 1 min for 
40 cycles, and then 72 °C for 10 min using an ABI Veriti 
fast thermal cycler. Visualization and Sanger sequencing 
of the PCR products were performed identically com-
pared to the 18S rRNA methodology with the exception 
of the primers used. For sequencing, PocPowDHFR-
exF, PocPowDHFR-exR, and a third internal primer, 
PocPowDHFR-inR (5′-TTTCCATTKGTTTCCCCTC 
T-3′) were used. Sequences for each specimen were 
aligned and verified using a BLAST search to further con-
firm the sub-species identification. Alignments of P. ovale 
sequences were performed using Mega6 software [17]. 
Genetic and peptide sequences between the enrolled 
specimens and complete P. ovale sequences that were 
previously reported (GenBank: EU266601, EU266604–
EU266618, GQ250090, GQ250091, KP050409, and 
KP05413–KP050415) [2, 7, 18] were compared.
Statistical analysis
Reported parasitaemia, morphological features (includ-
ing Schüffner’s stippling), pan-aldolase antigen-positiv-
ity, 18S gene copy number, year of import, and region of 
acquisition were compared between the two sub-species. 
Parasitaemia was treated as categorical data by record-
ing if the percentage of parasites observed were  <0.1 
or  ≥0.1%, as the former category is a convention used 
by PHOL laboratory technicians. Categorical variables 
were compared using Yates’ corrected Chi squared analy-
sis or Fisher’s exact test, and continuous variables using 
Mann–Whitney U tests using GraphPad Prism 6 (Graph-
Pad Software, CA, USA). Level of significance was set at 
p < 0.05.
Results
Of 49 isolates of P. ovale identified from October 2006 
to July 2015, ten (20.4%) were identified through 2010, 
while 39 (79.6%) were identified in or after the year 2011, 
with 24 (49%) identified in 2013 or 2014, the last two 
full years in the enrolment period. Country of exposure 
data were available for 17/49 (34.7%) specimens, with 
Nigeria being the most well represented source country 
(n = 9, 18.4%). Of the 17 isolates with an attached travel 
history, 15 (88.2%) were acquired in West Africa, with 
represented source countries of Nigeria, Ghana (n = 2), 
Ivory Coast (n = 1), Liberia (n = 1), Sierra Leone (n = 1), 
Congo (n = 1), and Cameroon (n = 1). Two isolates were 
imported from East or Saharan Africa, one each from 
Tanzania and the Sudan.
Of 49 total isolates, 22 P. ovale curtisi and 27 P. ovale 
wallikeri isolates were identified by 18S rRNA sequenc-
ing (Table 1). Region of acquisition did not differ between 
sub-species (p  =  1.00). Both sub-species appeared to 
emerge simultaneously in the past five years, with no 
difference between sub-species: six (27.3%) isolates of P. 
ovale curtisi were identified prior to 2011, and 16 (72.7%) 
in or after 2011, compared to four (14.8%) isolates of P. 
ovale wallikeri identified prior to 2011, and 23 (85.2%) in 
or after 2011 (p = 0.31) (Fig. 1).
Microscopy and RDT
Records of pan-aldolase antigen result and morphologi-
cal features were absent for one specimen, resulting in 
the omission of this isolate from relevant calculations. 
Median parasitaemia (by microscopy) of specimens 
positive for P. ovale curtisi was <0.1% (range <0.1–0.8%), 
while for P. ovale wallikeri it was  <0.1% (range  <0.1–
0.5%), and no difference was found (p = 0.99). There was 
no difference found in pan-aldolase antigen-positivity, 
where it was detectable in 11 (50.0%) specimens contain-
ing P. ovale curtisi and 11 (42.3%) specimens containing 
P. ovale wallikeri (p = 0.81). Pan-aldolase positivity for all 
specimens was 45.8%.
When comparing morphological features (Table  2), 
it was noted that all eight P. ovale parasites without 
Schüffner’s stippling were P. ovale wallikeri (p  =  0.02) 
(Fig.  2). Parasitaemia (p  =  0.20), 18S rRNA gene copy 
number (p  =  0.50), and pan-aldolase antigen positiv-
ity (p =  0.40), were not found to be differentially asso-
ciated with Schüffner’s stippling. Data on time between 
specimen collection and receipt were missing for two P. 
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Table 1 Pan-aldolase antigen-positivity (T2), parasitaemia, 18S rRNA gene copy number, reported Schüffner’s stippling, 
and the number of days between blood collection and processing Plasmodium ovale curtisi and Plasmodium ovale wallik-
eri specimens are recorded
Specimen 
number
















1 P. ovale curtisi + 0.8 11,649 + 1 2014 Ivory Coast
2 P. ovale curtisi + 0.6 5054 + 1 2014 Nigeria
3 P. ovale curtisi − 0.3 2132 + 7 2014 Unknown
4 P. ovale curtisi + 0.3 1928 + 1 2014 Unknown
5 P. ovale curtisi + 0.2 16,807 + 0 2012 Unknown
6 P. ovale curtisi + 0.2 626 + 0 2014 Unknown
7 P. ovale curtisi + 0.2 831 + 0 2014 Unknown
8 P. ovale curtisi + 0.1 3093 NA NA 2006 Unknown
9 P. ovale curtisi + 0.1 8445 + 1 2011 Ghana; Nigeria
10 P. ovale curtisi − <0.1 8264 + 1 2009 Unknown
11 P. ovale curtisi − <0.1 3285 + NA 2009 Nigeria
12 P. ovale curtisi − <0.1 1765 + 0 2010 Unknown
13 P. ovale curtisi − <0.1 931 + 0 2010 Unknown
14 P. ovale curtisi − <0.1 1972 + 0 2011 Ghana
15 P. ovale curtisi + <0.1 4962 + NA 2007 Unknown
16 P. ovale curtisi − <0.1 302 + 1 2012 Unknown
17 P. ovale curtisi − <0.1 855 + 0 2014 Nigeria
18 P. ovale curtisi + <0.1 2088 + 1 2015 Nigeria
19 P. ovale curtisi − <0.1 538 + 1 2013 Tanzania
20 P. ovale curtisi + <0.1 2991 + NA 2014 Unknown
21 P. ovale curtisi − <0.1 325 + 1 2014 Unknown
22 P. ovale curtisi − <0.1 2637 + 1 2013 Unknown
23 P. ovale wallikeri − 0.5 12,709 − 0 2011 Unknown
24 P. ovale wallikeri + 0.5 2835 − 0 2014 Unknown
25 P. ovale wallikeri + 0.4 5013 + 0 2013 Unknown
26 P. ovale wallikeri + 0.3 7107 + 1 2008 Unknown
27 P. ovale wallikeri − 0.3 6826 + 0 2011 Sudan
28 P. ovale wallikeri + 0.3 15,840 + 4 2012 Liberia
29 P. ovale wallikeri + 0.3 8697 + 0 2012 Nigeria
30 P. ovale wallikeri + 0.3 3897 + 0 2014 Unknown
31 P. ovale wallikeri − 0.15 114 + 1 2013 Unknown
32 P. ovale wallikeri + 0.1 2160 + 0 2013 Unknown
33 P. ovale wallikeri − 0.1 91 + 0 2014 Unknown
34 P. ovale wallikeri − <0.1 985 − 0 2009 Unknown
35 P. ovale wallikeri + <0.1 4402 + 1 2010 Unknown
36 P. ovale wallikeri − <0.1 752 + 1 2011 Unknown
37 P. ovale wallikeri − <0.1 935 + 0 2011 Sierra Leone
38 P. ovale wallikeri − <0.1 538 + 1 2012 Unknown
39 P. ovale wallikeri − <0.1 739 − 1 2013 Unknown
40 P. ovale wallikeri NA <0.1 4 + 2 2009 Nigeria
41 P. ovale wallikeri − <0.1 364 + 0 2012 Congo
42 P. ovale wallikeri + <0.1 1898 − NA 2013 Cameroon
43 P. ovale wallikeri + <0.1 435 + 0 2014 Unknown
44 P. ovale wallikeri − <0.1 51 + 0 2013 Nigeria
45 P. ovale wallikeri + <0.1 45 + 1 2014 Unknown
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ovale wallikeri specimens without Schüffner’s stippling, 
and four P. ovale curtisi specimens, where three P. ovale 
curtisi specimens had Schüffner’s stippling and the other 
specimen had no morphological features recorded. No 
significant difference in time for specimen processing 
between specimens with and without Schüffner’s stip-
pling was noted (p = 0.57).
18S gene copy number
18S rRNA gene copy number was found to be not nor-
mally distributed among all samples based on the 
D’Agostino-Pearson normality test, p  <  0.0001. Median 
18S rRNA gene copy number for P. ovale curtisi and P. 
ovale wallikeri were 2110/µL (range 302–16,807/µL) and 
844/µL (range 4–15,840/µL), respectively (p = 0.09).
Dihydrofolate reductase‑thymidylate synthase (dhfr‑ts)
Partial sequences of dfhr-ts could be obtained in 16 P. 
ovale wallikeri and seven P. ovale curtisi. In 26/49 iso-
lates, the dhfr-ts region selected could not be amplified by 
the selected primer set. Several differences in the peptide 
sequences between P. ovale curtisi and P. ovale wallikeri 
were observed (Table  3). Non-synonymous mutations 
were observed within the P. ovale wallikeri isolates as 
previously reported [2]. Specifically, deletions of two or 
four amino acids (i.e., TA252–253 or TATA252–255) 
were identified in six and one P. ovale wallikeri isolates, 
respectively (Table 3). Furthermore, due to an ambiguity 
in the nucleic acid sequence, potential Y359F and Y366F 
mutations were observed. Finally, for one specimen, a 
H285Q mutation was recorded for one P. ovale wallik-
eri isolate. While Y359F and Y366F mutations are not 
expected to change any amino acid properties, a H285Q 
indicates a change from a basic histidine to a polar, 
uncharged glutamine. Among the sequences analysed in 
this study, polymorphisms specific to either sub-species 
were not observed (Table 4). One P. ovale wallikeri speci-
men did have a I169L mutation, although this does not 
reflect any changes in amino acid properties. 
Discussion
Plasmodium ovale is increasingly observed among travel-
lers, and due to its ability to relapse months to years after 
primary infection; unlike the more common and severe 
P. falciparum, its ability to inflict acute morbidity contin-
ues long after the immediate post-travel period. The data 
reported herein underscore the anecdotal impression 





















46 P. ovale wallikeri − <0.1 256 − 1 2013 Nigeria
47 P. ovale wallikeri − <0.1 488 + 0 2013 Unknown
48 P. ovale wallikeri − <0.1 187 − NA 2012 Unknown




































Fig. 1 Plasmodium ovale isolates confirmed by Public Health 
Ontario Laboratories by year of import. 2006 and 2015 represent 
partial calendar years (October–December 2006, and January–June 
2015). Emergence of P. ovale was equally distributed among the two 
sub-species, with six (27.3%) isolates of P. ovale curtisi identified prior 
to 2011, and 16 (72.7%) in or after 2011, compared to four (14.8%) 
isolates of P. ovale wallikeri identified prior to 2011, and 23 (85.2%) in 
or after 2011 (p = 0.31)
Table 2 Number of  isolates with  Schüffner’s stippling 














Page 6 of 11Phuong et al. Malar J  (2016) 15:550 
among travellers returning from West Africa, with almost 
80% of imports to PHOL occurring in the last five years. 
Between 2007 and 2012, P. ovale diagnoses climbed from 
one per year to eight per year at PHOL [12]. Although it 
appeared in this study that many more P. ovale wallikeri 
isolates were imported in the past five years compared 
to P. ovale curtisi, this difference was not significant, 
although with higher numbers over a longer enrolment 
period such a difference may emerge.
Due to widespread attrition of trained microscopists 
in laboratories of non-malaria endemic regions, such as 
North America, diagnosis of malaria is becoming increas-
ingly reliant on RDT and molecular methods. However, 
given the extremely poor sensitivity of standard RDT for 
P. ovale infection [19], as well as typically low parasitae-
mia, under- and delayed diagnosis are increasingly likely. 
In addition, diagnostic morphologic features may not be 
demonstrable in the setting of extremely low parasitae-
mia, prompting empiric use of anti-malarials for a patient 
whose malaria screen is initially reported as “Plasmodium 
spp.” pending confirmatory molecular analysis. Standard 
choice of empiric oral therapy for uncomplicated malaria 
in North America is usually either atovaquone–proguanil 
(AP), or more rarely, artemether-lumefantrine. As resist-
ance to the proguanil component of AP is conferred in 
P. falciparum by step-wise mutations of the Dhfr gene, 
understanding whether or not similar mutations can 
accumulate in P. ovale, and whether such mutations are 
over-represented among a particular sub-species of P. 
ovale, is important for informing empiric choice of anti-
malarials in a patient with unspeciated malaria.
Among peptide sequences of DHFR-TS in isolates 
of P. ovale curtisi and P. ovale wallikeri studied herein, 
mutations known to confer antifolate resistance in other 
species of malaria, notably P. falciparum were not dem-
onstrated Furthermore, non-synonymous mutations 
within each sub-species, P. ovale wallikeri in particu-
lar, were also observed, confirming previous reports 
[2]. While there are variations in the peptide sequences 
between sub-species, it is unknown how these polymor-
phisms influence enzyme activity. Amino acids in the 
DHFR-TS that are believed to be involved in antifolate 
binding, and which are believed to be synonymous with 
amino acids found in other Plasmodium species, were 
found to be consistent throughout all examined P. ovale 
specimens, regardless of sub-species. These findings sug-
gest that the lack of clinical treatment failures observed 
in patients with P. ovale correlate well to gene sequences 
free of known markers of resistance, and are reassuring 
from the perspective of empiric choice of anti-malarials. 
It would be very unlikely, and unfortunate, for a traveller 
from West Africa with unspeciated malaria to be started 
empirically on chloroquine, which is actually the drug of 
choice for P. ovale, rather than AP.
Many reports have documented the existence of the 
two sub-species of P. ovale; it was previously unknown 
if parasitaemia, 18S rRNA gene copy number and the 
detection of the pan-aldolase antigen in BinaxNow RDT 
could differ between them. The results reported herein 
indicate that P. ovale curtisi and P. ovale wallikeri do not 
differ significantly by parasitaemia, pan-aldolase antigen-
positivity or 18S rRNA gene copy number. A general low 
pan-aldolase antigen-positivity rate among all specimens 
was observed, which is consistent with previous litera-
ture [19, 20]. A lack of discernible Schüffner’s stippling 
may be a feature specific to P. ovale wallikeri, and may 
Fig. 2 Giemsa-stained microscopy of Plasmodium ovale. Note prominent Schüffner’s stippling in a, compared to the absence of Schüffner’s stip-
pling in b
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Table 4 Amino acids at the Dhfr-ts domain believed to affect antifolate binding
ND not determined
Plasmodium ovale isolate Amino acid number in Dhfr‑ts domain relevant to antifolate binding
53 57 58 61 113 116 169 190 503 523
P. ovale curtisi KP050414.1
 2 ND ND ND ND ND ND I T ND ND
 4 ND F S T S S I T R C
 8 ND F S T S S I T R C
 9 ND F S T S S I T R C
 17 ND ND ND ND ND ND ND ND ND ND
 21 ND ND ND ND ND ND I T ND ND
 22 ND F S T S S I T R C
P. ovale curtisi EU266611 D F S T S S I T R C
P. ovale curtisi EU266608 D F S T S S I T R C
P. ovale curtisi EU266609 D F S T S S I T R C
P. ovale curtisi EU266610 D F S T S S I T R C
P. ovale curtisi EU266606 D F S T S S I T R C
P. ovale curtisi EU266607 D F S T S S I T R C
 23 ND ND ND ND S S I T R C
 24 D F S T S S I T R C
 26 ND F S T S S L T R C
 27 ND ND ND ND S S I T R C
 28 ND F S T S S I T R C
 29 ND ND ND ND S S I T R C
 30 D F S T S S I T R C
 33 ND F S T S S I T R C
 34 ND F S T S S I T R C
 35 D F S T S S I T R C
 37 D F S T S S I T R C
 39 ND F S T S S I T R C
 41 D F S T S S I T R C
 42 ND F S T S S I T R C
 43 ND ND ND ND S S I T R C
 44 ND ND ND ND S S I T R C
P. ovale wallikeri KP050415.1 D F S T S S I T R C
P. ovale wallikeri KP050409.1 D L R T S S I T R C
P. ovale wallikeri EU266612 D F S T S S I T R C
P. ovale wallikeri EU266613 D F S T S S I T R C
P. ovale wallikeri EU266614 D F S T S S I T R C
P. ovale wallikeri EU266615 D F S T S S I T R C
P. ovale wallikeri EU266617 D F S T S S I T R C
P. ovale wallikeri GQ250090 D F S T S S I T R C
P. ovale wallikeri EU266616 D F S T S S I T R C
P. ovale wallikeri EU266618 D F S T S S I T R C
P. ovale wallikeri GQ250091 D F S T S S I T R C
P. ovale wallikeri EU266601 D F S T S S I T R C
P. ovale wallikeri EU266604 D F S T S S I T R C
P. ovale wallikeri EU266603 D F S T S S I T R C
P. ovale wallikeri EU266605 D F S T S S I T R C
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further challenge microscopists who rely on this as one of 
the features to distinguish P. ovale from the similarly low 
parasitaemic P. malariae, particularly when not all differ-
entiating morphologies are present on the slide. As previ-
ously noted, P. ovale wallikeri cases appeared to increase 
more so than P. ovale curtisi in the past five years, and if 
this trend were to continue, the lack of Schüffner’s stip-
pling may further hinder interpretation of microscopy 
and RDT results. The lack of Schüffner’s stippling among 
P. ovale wallikeri isolates joins other findings that the sub-
species have distinguishing clinical characteristics, such 
as latency and degree of thrombocytopaenia, in addition 
to their genotype [9, 10]. That said, molecular techniques 
are still the most accurate and specific method for deter-
mining sub-species of P. ovale.
Limitations of the study include a relatively small sam-
ple size which limited the ability to comment on the 
possible emergence of variant over classic P. ovale, an ina-
bility to investigate DHFR-TS enzyme activity, and pos-
sible variation in Schüffner’s stippling visualization due 
to factors such as the age of the Giemsa stain or opera-
tor experience. As well, the attempt to account for time 
for specimen processing may be limited in terms of pre-
cision, as the exact time when blood was collected from 
patients was unavailable, meaning that this variable could 
only be analysed on the order of days rather than hours, 
the latter of which would have been ideal. Full clini-
cal linkage of specimens was lacking and therefore data 
on latency of P. ovale infection or full travel details were 
unavailable. The limited availability of gene sequences in 
GenBank also restricted the ability to investigate the full 
dhfr-ts region and other potential virulence factors that 
could theoretically differ between the sub-species.
Future studies, including whole genome sequencing 
of P. ovale, will facilitate identification of genes of other 
known Plasmodium virulence factors that have not been 
previously investigated in P. ovale. In particular, nucleo-
tide and peptide heterogeneity between the two sub-spe-
cies can be further explored across a larger sample size to 
extrapolate potential consequences in protein structure. 
Clinical outcomes can also be investigated prospectively 
to determine whether specific polymorphisms have any 
effect on delayed parasite clearance and treatment failure. 
Future prospective investigation of the Schüffner’s stip-
pling finding in P. ovale wallikeri versus P. ovale curtisi by 
diligent exclusion of competing factors, such as time to 
specimen processing, would further add to the literature 
around morphological identification, considering that 
microscopy remains the gold standard diagnostic test in 
malaria, and is often the only diagnostic test available in 
under-resourced settings.
Conclusions
This study demonstrates that the two P. ovale sub-spe-
cies, P. ovale curtisi and P. ovale wallikeri, are increasing 
among travellers to West Africa, and do not differ signifi-
cantly by parasitaemia, RDT positivity, or 18S rRNA gene 
copy number, and may therefore be treated similarly from 
a clinical management perspective. A lack of discernible 
Schüffner’s stippling on microscopic examination may 
be a feature specific to P. ovale wallikeri, and one which 
may significantly challenge the diagnosis of this typically 
low parasitaemic species, especially as loss of technical 
expertise in diagnostic laboratories continues. Although 
nucleotide polymorphisms in dhfr-ts were identified, it 
is unknown if they could lead to antifolate resistance, as 
they did not occur in regions known to confer antifolate 
resistance in other species such as P. falciparum. Further 
interrogation of the relevance of such genetic differences 
is warranted.
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